Dihydrotestosterone promoted kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors (AR and GR), which could be attenuated by AR and GR knockdown [115]. This evidence concerns the gene NR3C1 and kidney cancer.